Euphrasia Officinalis 6 X Globules ; Tablet is a Health Canada–registered human drug (DIN 02232119) held by Boericke And Tafel Inc., containing Euphrasia Officinalis. Health Canada lists its status as Cancelled Post Market (status date 06 Oct 2004). Nexara Health has matched 15 registrations of Euphrasia Officinalis across 3 other regulated markets.
Health Canada registration
| DIN | 02232119 |
|---|---|
| Brand name | Euphrasia Officinalis |
| Active ingredient | Euphrasia Officinalis |
| Strength | 6 X |
| Dosage form | Globules ; Tablet |
| Route | Sublingual |
| Company | Boericke And Tafel Inc. |
| Status | Cancelled Post Market — 06 Oct 2004 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Euphrasia Officinalis registered in other markets
15 registrations of the same molecule in 3 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Ireland | Euphrasia | A. Nelson & Company Limited | Pillules | Not marketed | HPRA | |
| Malaysia | One Vision Plus Eyebright Extract 350mg Capsule | Intan Biotech Industries Sdn Bhd | Natural Product | PRODUCT APPROVED | NPRA | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Euphrasia Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Euphrasia Officinalis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Euphrasia Officinalis (DIN 02232119) marketed in Canada?
No. Health Canada lists DIN 02232119 as Cancelled Post Market as of 06 Oct 2004.
Who holds the Canadian licence for this product?
Boericke And Tafel Inc. is the company of record in the Health Canada Drug Product Database.
Is Euphrasia Officinalis registered outside Canada?
Yes — Nexara Health has matched 15 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02232119, status date 2004-10-06; national medicine registries: FDA NDC, HPRA, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02232119, status date 2004-10-06; national medicine registries: FDA NDC, HPRA, NPRA.
Health Canada Drug Product Database (DPD), DIN 02232119, status date 2004-10-06; national medicine registries: FDA NDC, HPRA, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.